Analysis of Thrombotic Adverse Reactions of COVID-19 AstraZeneca Vaccine Reported to EudraVigilance DatabaseArticle Published on 2021-04-162022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] Adverse Adverse drug reaction adverse event adverse events Adverse reaction Adverse reactions Analysis assessment AstraZeneca benefit Blood Characteristics Committee Comorbidities Conducting COVID-19 database death effective EMA European country European Medicines Agency event fatality group identify pandemic pharmacovigilance reaction Research retrospective Safe specificity submitted the vaccine thrombosis thrombotic vaccination Vaccine Vaccines World Health Organization’ [DOI] 10.3390/vaccines9040393 PMC 바로가기 [Article Type] Article
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trialSARS-CoV-2 백신(비활성화, Vero 세포)의 효능과 안전성을 평가하기 위한 무작위 이중 맹검 위약 대조 임상 3상 시험: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약Letter Published on 2021-04-132022-09-10 Journal: Trials [Category] MERS, SARS, 비임상, 임상, 치료기술, [키워드] 1:1 24 hour 24 hours 95% confidence interval Activation Active surveillance administration Administrative Personnel Adverse adverse event adverse events Adverse reaction Adverse reactions African green monkey age Algorithm Aluminium aluminium hydroxide anaphylaxis Antibody test Antibody titer Antigen Arm asplenia assigned assumed assumption Autoimmune baseline bleeding disorders Blinding blood product blood products blood sample Blood samples breastfeeding women breath carried Cell culture China chloride Clinical efficacy clinical trial code Cohort cohorts comparator consent form cooperation Corticosteroid Corticosteroids COVID-19 COVID-19 cases COVID-19 disease COVID-19 symptoms COVID-19 test criteria Critical CRO Data and Safety Monitoring Board Day development diary dihydrogen DIHYDROGEN PHOSPHATE disease disodium disodium hydrogen phosphate dissemination dose dose of vaccination double blind double-blind double-blind study Efficacy Efficacy and safety element eligible Endpoint enrolled enrolment ethics committee evaluate event excluded exclusion criteria expected Follow-up follow-up period Frequency Gender genders green monkey group groups healthcare Healthcare professional healthcare professionals higher risk HIV infection hospital Hospitalization hydrogen Hydrogen phosphate hydroxide hypersensitivity identity IgG level IgG levels IgG test immunogenicity Immunoglobulin immunoglobulins immunosuppressive immunosuppressive therapy inactivated Inactivated Vaccines incidence incidence rate include Inclusion individual information informed consent form initiated Interactive Web Response System intramuscular dose investigator IWRS IWRS system kidney knowledge Local local reactions management medical doctors medical emergency Ministry of Health mortality rates neutralizing antibody Neutralizing antibody titer Novel coronavirus number Nurses objective Omega Other participant PCR PCR positivity performed Phase III Clinical Trial phosphate Placebo placebo group placebo-controlled positive pregnancy test pregnant preparation primary efficacy endpoint professional proportion protocol randomised randomised controlled trial randomised placebo controlled trial randomization Randomized Randomly Reactions receive recorded regimens Registration reported response risk risk of infection RT-PCR RT-PCR test RT-PCR tests Safety Monitoring Board Sample size SARS-CoV-2 vaccine SARS-CoV-2 virus screened second dose secondary Secondary objectives Serious Adverse Event Serious Adverse Events seroconversion rate Seropositivity severity severity of COVID-19 shown Sinovac sodium Sodium chloride sodium dihydrogen phosphate Sponsor status study group Study protocol subject subject’ supplementary material Symptom symptomatic symptomatic case symptomatic cases System systemic adverse reaction the ethics committee the timing the vaccine therapy Treatment treatment arm Trial Turkey two-sided vaccinated groups vaccination Vaccine Vero Vero Cell Web website width with COVID-19 within 6 months [DOI] 10.1186/s13063-021-05180-1 PMC 바로가기 [Article Type] Letter
Acute fluconazole toxicity: a case presenting with protean manifestations including systemic and neurologic symptomsArticle Published on 2021-03-312024-08-30 Journal: Postgrad Med [Category] 백선증, [키워드] acute renal insufficiency Adverse reactions fluconazole Polyneuropathy Thrombotic thrombocytopenic purpura PMC 바로가기
Mini-Review Discussing the Reliability and Efficiency of COVID-19 VaccinesReview Published on 2021-03-242022-10-31 Journal: Diagnostics [Category] COVID-19, [키워드] administration Adverse reactions affected age age and sex All adverse event alleviate approved article beta-coronavirus conducted coronavirus 2 COVID-19 database death develop died dose-dependent drug Effect Efficacy Efficacy and safety Evidence FIVE form Frequency individual Johnson & Johnson manuscript Mild Moderna Pfizer–BioNTech produced ranged recipient recipients reported respiratory Safe Safety SARS-CoV-2 searched severe adverse reactions Sex Side effects Sinopharm Sinovac the patient Vaccine Vaccines [DOI] 10.3390/diagnostics11040579 PMC 바로가기 [Article Type] Review
Multicenter point prevalence evaluation of the utilization and safety of drug therapies for COVID-19 at the onset of the pandemic timeline in the United States미국에서 유행성 타임라인이 시작될 때 COVID-19에 대한 약물 요법의 사용 및 안전성에 대한 다기관 점 유병률 평가Multicenter Study Published on 2021-03-182022-09-11 Journal: American journal of health-system pharmacy : AJHP [Category] SARS, 치료제, [키워드] addition ADR ADRS Adverse drug reaction Adverse drug reactions Adverse reaction Adverse reactions antagonist Asthma Characteristics clinical Clinical data clinical trial clinical trials combination therapy Community Comprehensive conducted coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 treatments drug reaction drug therapy enrolled evaluated hospital Hydroxychloroquine identify interleukin interleukin-6 lAbel medication medication safety medications mitigate Most patient Most patients multicenter observational study occurred Odds ratio off-label pandemic Patient patients patients hospitalized patients treated patients with COVID-19 point prevalence Prevalence prevalence study random Random sample receiving Remdesivir SARS-CoV-2 supported supportive care the United State Therapies therapy treated Treatment while [DOI] 10.1093/ajhp/zxaa426 PMC 바로가기 [Article Type] Multicenter Study
Health Care Workers’ Reasons for Choosing Between Two Different COVID-19 Prophylaxis Trials in an Acute Pandemic Context: Single-Center Questionnaire Study급성 전염병 상황에서 의료 종사자가 두 가지 다른 COVID-19 예방 실험 중에서 선택하는 이유: 단일 센터 설문 조사 연구Original Paper Published on 2021-02-252022-09-10 Journal: Journal of Medical Internet Research [Category] MERS, 임상, [키워드] Adverse reaction Adverse reactions all subject all subjects asked benefit chose clinical trial clinical trials combination therapy contribute COVID-19 Efficacy emtricitabine evaluate expected followed by Health health benefits Health care Health care worker health care workers Hydroxychloroquine independent initial screening initiated majority melatonin motivation Nurse Nurses objective offered pandemic personnel physician Placebo pre-exposure professional practice Prophylaxis prophylaxis strategy Randomized reason respond Result Safety SARS-CoV-2 SARS-COV-2 infection screened selected significant difference significant differences tenofovir tenofovir disoproxil tested Treatment Trial trials Volunteer volunteers volunteers, web-based survey workplace safety [DOI] 10.2196/23441 PMC 바로가기 [Article Type] Original Paper
Spontaneous reported cardiotoxicity induced by lopinavir/ritonavir in COVID-19. An alleged past-resolved problemCOVID-19에서 로피나비르/리토나비르에 의해 유발된 자발적인 보고된 심장독성. 과거에 해결된 문제Article Published on 2021-02-012022-09-11 Journal: International journal of cardiology [Category] 신약개발, 치료제, [키워드] Adverse drug reaction Adverse drug reactions Adverse reaction Adverse reactions analyzed antiretroviral drug arrhythmia average baseline Bundle branch bundle branch block cardiac Cardiac arrhythmia Cardiotoxicity caution center Characteristics characterized collected conduction Conduction disorder COVID-19 COVID-19 pandemic drug combination drug-related side effects and adverse reactions ECGs functions hospital incidence Long Long QT syndrome Lopinavir Lopinavir-ritonavir Lopinavir-ritonavir drug combination. Lopinavir/ritonavir MOST National network offer Other pharmacovigilance Potassium potassium channel QTc QTC prolongation reflected Regional reported risk Ritonavir Side effect sodium Spontaneous syndrome Treatment treatment of COVID-19 ventricular ventricular arrhythmias [DOI] 10.1016/j.ijcard.2020.10.028 PMC 바로가기 [Article Type] Article
Drug-drug interactions with candidate medications used for COVID-19 treatment: An overviewCOVID-19 치료에 사용되는 후보 약물과의 약물-약물 상호작용: 개요Review Published on 2021-02-012022-09-11 Journal: Pharmacology Research & Perspectives [Category] 진단, 치료제, [키워드] Adverse reactions Chloroquine concomitant use coronavirus disease Coronavirus disease 2019 COVID-19 drug-drug interaction drugs hepatotoxicity increased risk Infection Interaction Kaletra Lopinavir Lopinavir/ritonavir medication medications occur occurred Patient Remdesivir retinopathy ribavirin risk Ritonavir serious adverse reaction Serious adverse reactions Tocilizumab Treatment [DOI] 10.1002/prp2.705 PMC 바로가기 [Article Type] Review
Impfungen in der DermatologieLeitthema Published on 2021-01-212024-09-04 Journal: Der Hautarzt; Zeitschrift Fur Dermatologie, Venero [Category] 대상포진, [키워드] Adverse reactions atopic dermatitis Atopische Dermatitis Impfreaktionen Intolerance reactions Intoleranzreaktionen Lichen planus psoriasis [DOI] 10.1007/s00105-020-04751-8 PMC 바로가기 [Article Type] Leitthema
Drugs supply and pharmaceutical care management practices at a designated hospital during the COVID-19 epidemicCOVID-19 전염병 동안 지정된 병원의 약물 공급 및 의약품 관리 관행Review Published on 2021-01-012022-08-31 Journal: Research in social & administrative pharmacy : RSA [Category] 치료제, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus adjusted Adverse reaction Adverse reactions affected assigned Care caused characterized China conducted coronavirus coronavirus disease Coronavirus disease-19 Coronavirus disease-19 (COVID-19) COVID-19 COVID-19 diagnosis COVID-19 epidemic COVID-19 patient COVID-19 patients cured Diagnosis drug Drug supply Epidemic Health Organization hospital lAbel management medication medication errors mood Northeast China Nosocomial infection Nosocomial infections occurred off-label offer outbreak pandemic participated pharmaceutical Pharmaceutical service Practice Prevention and control Region respiratory serious adverse reaction service offers shown the epidemic Treatment World Health Organization [DOI] 10.1016/j.sapharm.2020.04.001 PMC 바로가기 [Article Type] Review